Table 1. Demographic and clinical characteristics.
| Median | Range | |||
|---|---|---|---|---|
| Age (years) | 62 | 36–80 | ||
| Body mass index (kg/m 2 ) (BMI) | 31 | 27–45 | ||
| Hospital stay in days after surgery | 2 | 1–7 | ||
| Operation time (min) | 121 | 95–245 | ||
| Blood loss (mL) | 60 | 40–150 | ||
| Tumor size (mm) | 8 | 6–80 | ||
| Depth of myometrial invasion | ||||
| N: 93 | Percentage | |||
| No infiltration | 3 | 3 | ||
| <%50 | 66 | 70 | ||
| >%50 | 22 | 25 | ||
| Presence of lymphovascular space invasion | 18 | 19 | ||
| Histology | ||||
| N: 93 | Percentage | |||
| Endometrioid | 68 | 73 | ||
| Clear cell | 9 | 9.6 | ||
| Serous | 6 | 6.4 | ||
| Mix type (squamous adenocarcinoma) | 8 | 7 | ||
| Carcinosarcoma | 2 | 2 | ||
| Müsinöz adenoca | 2 | 2 | ||
| Sentinel lymph node detection (SLND) rates according to risk and body mass index | ||||
| Risk of endometrium carcinoma | N: 93 | Percentage | Number of SLND | Percentage |
| Low risk (FIGO Grade 1–2 endometrioid type) | 63 | 67 | 65 | 100 |
| Hıgh risk (FIGO Grade 3, non endometrioid type) (Two clear cell cases occurred from the polyp base Five endometrioid Ca were Grade 3) |
30 | 33 | 28 | 93 |
| Patients body mass index | Number of patients | Percentage | Number of SLND | Percentage |
| Body mass index<31 | 55 | 59 | 55 | 100 |
| Body mass index>31 | 38 | 41 | 36 | 95 |
| Total | 93 | 100 | 91 | 97.8 |